Epigral Limited (NSE:EPIGRAL)
India flag India · Delayed Price · Currency is INR
1,781.20
-14.90 (-0.83%)
Jun 6, 2025, 3:29 PM IST

Epigral Revenue

In the fiscal year ending March 31, 2025, Epigral had annual revenue of 25.50B INR with 32.19% growth. Epigral had revenue of 6.28B in the quarter ending March 31, 2025, with 19.63% growth.

Revenue
25.50B
Revenue Growth
+32.19%
P/S Ratio
3.04
Revenue / Employee
25.58M
Employees
997
Market Cap
77.49B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202525.50B6.21B32.19%
Mar 31, 202419.29B-2.59B-11.84%
Mar 31, 202321.88B6.37B41.10%
Mar 31, 202215.51B7.22B87.18%
Mar 31, 20218.29B2.19B35.89%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UltraTech Cement 759.55B
Asian Paints 338.59B
Grasim Industries 1,484.78B
Vedanta 1,507.25B
Pidilite Industries 131.40B
Solar Industries India 75.40B
Shree Cement 192.83B
Jindal Steel & Power 497.65B
Revenue Rankings